Prestige Consumer Healthcare Financial Ratios
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare ratio analysis
Prestige Consumer Healthcare earned a net margin of 17.5% in FY 2026, down from 18.9% a year earlier. Gross margin was 54.7% compared with a median of 56.7% over the prior 9 years. Return on equity reached 10.1%, meaning Prestige Consumer Healthcare generated 0.10 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.53 versus 0.54 the year before, and the current ratio was 3.57. At the end of FY 2026, PBH traded at 13.4 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 5.3 to 42.7, with a median of 13.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Prestige Consumer Healthcare financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 13.42 | 19.31 | 17.40 | — | 13.14 | 13.25 | 13.51 | — | 5.32 | 42.74 |
| Price / sales | 2.34 | 3.62 | 3.21 | 2.77 | 2.45 | 2.29 | 1.98 | 1.60 | 1.72 | 3.34 |
| Price / book | 1.35 | 2.24 | 2.18 | 2.16 | 1.69 | 1.59 | 1.63 | 1.42 | 1.52 | 3.58 |
| Gross margin | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% |
| Operating margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% |
| Net margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% |
| Free cash flow margin | 22.6% | 21.4% | 21.3% | 19.7% | 23.0% | 22.6% | 21.0% | 18.3% | 19.0% | 16.5% |
| Return on equity (ROE) | 10.1% | 11.7% | 12.6% | -5.7% | 13.0% | 12.1% | 12.2% | -3.3% | 28.8% | 8.4% |
| Return on assets (ROA) | 5.4% | 6.3% | 6.3% | -2.5% | 5.6% | 4.8% | 4.0% | -1.0% | 9.0% | 1.8% |
| Debt / equity | 0.53 | 0.54 | 0.69 | 0.93 | 0.94 | 1.09 | 1.48 | 1.64 | 1.69 | 2.67 |
| Current ratio | 3.57 | 4.20 | 3.20 | 2.44 | 2.04 | 2.21 | 2.44 | 2.37 | 2.46 | 2.06 |
| Revenue growth | -4.3% | 1.1% | -0.2% | 3.8% | 15.2% | -2.0% | -1.3% | -6.3% | 18.0% | 9.4% |
| EPS growth | -8.9% | 2.9% | — | -140.8% | 24.3% | 16.9% | — | -110.9% | 387.7% | -30.9% |